News

The company Lumier Pharma received the license for the import of medicinal products

1 March 2013
The State Administration of Ukraine on Medicinal Products 03.01.2013, after consideration of the application and documents, decided to issue LLC “Lumier Pharma” license

In Ukraine the company “Lumiere Pharma” and MSD (Schering-Plough) have launched a new joint project concerning the production of the innovative preparation UNITRON (PEG-interferon alfa-2b) for the treatment of viral hepatitis.

2 November 2012
Within the framework of the joint project the preparation UNITRON (PEG-interferon alpha-2b) was registered in Ukraine which is produced from «in bulk» of the company MSD (Schering-Plough) for the treatment of hepatitis B and C in two dosage forms.

LLC “Lumiere Pharma” – Sponsor of the Day of Breast Cancer Fighting

20 October 2012
The domestic pharmaceutical manufacturer LLC “Lumiere Pharma” whose mission is to provide the population of Ukraine with innovative high-quality import-substituting preparations for the treatment of socially important diseases, supported and sponsored the public awareness action “Be attentive to them” on the occasion of the All Ukrainian Day of breast cancer fighting.

The company “Lumiere Pharma” has contributed to the realization of the charitable action “I will survive!”

11 October 2012
September 12, 2012, a charity concert “I will survive!” was held in Kiev, the initiator of which was the “Association for the disabled and patients with chronic lymphoproliferative disorders” and the rock band DRUGA Rika.

Receiving of a GMP certificate – strategically important event for the company “Lumiere Pharma”

11 September 2012
August 27, 2012 the State Service of Ukraine for Medicinal Products issued a certificate of GMP compliance to LLC “Lumiere Pharma”.

Themutual meeting of Lumier Pharma LLC and F.Hoffmann-La Roche Ltd with the representatives of the All-Communities Advisory Council on Access to Treatment in Ukraine (UCAB )

14 March 2012
On March 14, 2012, the mutual meeting with the representatives of the All-Communities Advisory Council on Access to Treatment in Ukraine was held. The main objective of the meeting was to introduce to the meeting participants the medicine PEGFERON, PEG-interferon alpha 2, manufactured by Lumier Pharma and the F.Hoffmann-La Roche Ltd Company.

Next stage of cooperation between Lumier Pharma LLC and F.Hoffmann-La Roche Ltd

7 February 2012
At the beginning of 2012, Lumier Pharma registered two medications developed by the F.Hoffmann-La Roche Ltd Company that will be produced in Ukraine in the framework of a mutual project with Lumier Pharma.

Oktapharma specialists performed the audit of the Lumier Pharma Company

28 July 2011
In June 2011, the specialists of the world’s leading manufacturer of high-quality plasma medicines, the Octapharma Company, performed external audit of the Lumier Pharma Company.

F.Hoffmann-La Roche Ltd performed the inspection of Lumier Pharma production capacity and internal processes

25 March 2011
The world’s leading manufacturer of pharmaceuticals, the F.Hoffmann-La Roche Ltd Company, conducted an examination and inspection of Lumier Pharma production capacity and internal processes to verify the successful fulfillment of the final stage of biotechnological medicines production in Ukraine.

Lumier Pharma LLC and F.Hoffmann-La Roche Ltd social project on the production of PEGFERON, PEG-interferon alpha-2a in Ukraine

15 February 2010
Commenced in March, 2010 was the first stage of work on the mutual social project of the world’s leading manufacturer of pharmaceuticals, the F.Hoffmann-La Roche Ltd Company, and the domestic company Lumier Pharma.